TD Cowen lifted its price objective on shares of Iovance Biotherapeutics.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen lifted its price objective on shares of Iovance Biotherapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Iovance Biotherapeutics
American biopharmaceutical startup
Nothing else this week.
Related events
- TD Cowen raised its price objective on Illumina stock on August 26, 2026.
- TD Cowen boosted its price objective on Elevance Health, while the National Pension Service reduced its holdings and filed 13F with the SEC.
- TD Cowen and Mizuho Securities have both lifted their price targets for Medpace shares.
- TD Cowen dropped its price objective on Cogent Communications shares.
- TD Cowen raised price targets for GoodRx stock.